Cargando…

Commentary: Squamous cell carcinoma of the esophagus: Another target for checkpoint inhibition

Detalles Bibliográficos
Autor principal:	Whyte, Richard I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390151/ https://www.ncbi.nlm.nih.gov/pubmed/36003429 http://dx.doi.org/10.1016/j.xjon.2021.12.009

Ejemplares similares

Commentary: Surgical mitral plasticity: Another brick in the wall?
por: Calafiore, Antonio M., et al.
Publicado: (2020)

Commentary: Beware of the esophagus—it's never too late for a complication
por: Chang, Stephanie H.
Publicado: (2022)

Commentary: Invasive mucor requiring pneumonectomy—a surgeon's (and patient's) nightmare
por: Whyte, Richard I.
Publicado: (2021)

Commentary: Another tool in the toolbox for managing mitral annular calcification
por: Norton, Elizabeth L., et al.
Publicado: (2022)

Commentary: Another tool for the chronic thromboembolic pulmonary hypertension toolbox
por: Chan, Justin C.Y., et al.
Publicado: (2022)

Commentary: Another way to skin a cat, hardly ever
por: Alsoufi, Bahaaldin
Publicado: (2021)

Commentary: Another way to skin a rare and dangerous cat
por: Jaquiss, Robert D.B.
Publicado: (2021)

Commentary: Another step forward ischemic mitral regurgitation comprehension
por: Di Mauro, Michele, et al.
Publicado: (2020)

Commentary: Digital toxicity: Another side effect of COVID-19 pandemic
por: Akkara, John Davis, et al.
Publicado: (2021)

Commentary: Extremely early failure of transcatheter aortic valves—Another warning!
por: Antunes, Manuel J.
Publicado: (2020)

Commentary: Bioprosthetic pulmonary valve endocarditis: Another “arrow in our quiver”
por: Ali-Ghosh, Hani, et al.
Publicado: (2021)

Commentary: Nanobubbles—A promising technology or another therapy stuck in the laboratory?
por: Robinson, N. Bryce, et al.
Publicado: (2020)

Commentary: Another iteration of cell-based therapy for acute ischemia-reperfusion injury, this time in the spine
por: Herrmann, Jeremy L.
Publicado: (2021)

Commentary: Another way to band pulmonary arteries: Anatomic, hemodynamic, and scientific considerations
por: Kalfa, David
Publicado: (2021)

Invited Commentary: Neuraxial Anaesthesia for Appendectomy: Another Tool in the Toolbox
por: Hammarqvist, Folke, et al.
Publicado: (2021)

Prognostic value of biomarkers in primary small cell carcinoma of the esophagus
por: Wang, Yan, et al.
Publicado: (2020)

Beyond Squamous Cell Carcinoma: Basaloid Squamous Cell Carcinoma of the Esophagus
por: Song, Heeyah, et al.
Publicado: (2021)

Commentary on “Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma”
por: Peña-Cardelles, Juan Francisco, et al.
Publicado: (2022)

Commentary: We don't need no postop AF… All in all it's just another (β)-block in the wall
por: Mukherjee, Rupak
Publicado: (2020)

Peer commentary: in vitro gametogenesis: just another way to have a baby
por: Carbone, June
Publicado: (2016)

Squamous Cell Carcinoma and Neuroendocrine Carcinoma Colliding in the Esophagus
por: Dias, André Roncon, et al.
Publicado: (2010)

The mesenchymal stromal cell magic bullet finds yet another target
por: Masterson, Claire, et al.
Publicado: (2014)

Trimodal therapy in squamous cell carcinoma of the esophagus
por: Matuschek, C, et al.
Publicado: (2011)

Synchronous triple squamous cell carcinoma of the esophagus
por: Petroianu, Andy, et al.
Publicado: (2018)

The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung
por: Ichiki, Yoshinobu, et al.
Publicado: (2020)

One mental health problem influencing the risk for another, within individuals and between siblings. Commentary on Allegrini et al. (2022)
por: Middeldorp, Christel M.
Publicado: (2022)

Validation of tissue microarray technology in squamous cell carcinoma of the esophagus
por: Boone, Judith, et al.
Publicado: (2008)

Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial
por: Sano, Daisuke, et al.
Publicado: (2023)

Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle
por: Farina, Nicola, et al.
Publicado: (2022)

Basosquamous Carcinoma: A Commentary
por: Fotiadou, Christina, et al.
Publicado: (2021)

Another piece in the puzzle
por: Maxey, Thomas S, et al.
Publicado: (2005)

Not just another genome
por: Tautz, Diethard
Publicado: (2011)

A new chapter in immune checkpoint inhibitor therapy: starting with advanced lung squamous cell carcinoma
por: Fei, Kailun, et al.
Publicado: (2020)

Role of retinoic acid receptors in squamous-cell carcinoma in human esophagus
por: Bergheim, I, et al.
Publicado: (2005)

TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?
por: VIEIRA, Felipe Monge, et al.
Publicado: (2021)

Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck
por: Iacob, Razvan, et al.
Publicado: (2022)

A Case of Synchronous Squamous Cell Carcinoma in the Esophagus and Stomach
por: Lim, Sun Min, et al.
Publicado: (2012)

Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
por: Heise, Joachim W, et al.
Publicado: (2001)

Acute Dysphagia Caused by Sarcomatoid Squamous Cell Carcinoma of the Esophagus
por: Phelps, Benjamin J, et al.
Publicado: (2019)

Alterations of RNA splicing patterns in esophagus squamous cell carcinoma
por: Ding, Jiyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ko7n3c7e9b4fujrsept20fukl